Asymmetric power in the transnational innovation networks of Big Pharma
This article theoretically and empirically analyzes leader corporations’ innovation processes in contemporary capitalism. We highlight three characteristics: their transnational scope, the primacy of power or asymmetric relations exercised by leaders over the participants of their innovation circuits or networks, and the relevance of what we called technological competition and technological cooperation between leaders. Focusing on …
Asymmetric power in the transnational innovation networks of Big Pharma Read More »